Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Almac Pharma Services LLC
EIR
•Almac Pharma Services LLC•February 3, 2022

Almac Pharma Services LLC – FDA EIR, Feb 3, 2022

Record Details

An FDA Pre-Approval Inspection of Almac Pharma Services LLC in Audubon, PA, was conducted from January 19 to February 3, 2022. The inspection, guided by CPGM 7346.832, assessed the firm's readiness for commercial manufacturing linked to new ANDA and NDA applications, and included a follow-up on prior records requests. The inspection revealed two primary objectionable conditions, documented on a 2-item FDA Form 483.

First, the company failed to thoroughly investigate unexplained discrepancies. Specifically, recurrent incidents of blister packaging machine jams leading to burst gel capsules, impacting potential product quality, were logged as maintenance issues but not subjected to formal deviation investigations, violating 21 CFR 211.192. This equipment is crucial for packaging the pre-approval products.

Second, Almac Pharma Services LLC inadequately addressed a persistent issue of water leaks through the ceiling into manufacturing rooms, corridors, and the warehouse. Despite numerous past occurrences dating to 2018, corrective actions focused on superficial repairs (e.g., ceiling tiles) rather than comprehensive solutions for the identified root causes, such as roof and Air Handling Unit problems.

Management committed to submitting a written response to the FDA-483 observations within 15 business days.

Company
Almac Pharma Services LLC
Inspection date
February 3, 2022
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Ian Markwell (company_representative)
  • Marc English (company_representative)
  • Brandy N. Lepage (Consumer Safety Officer)
  • Harry Lindenmuth (recipient)
  • Robert Marshall (company_representative)
View Company Profile

ID · ae436155-1d2b-4336-b2c8-117cba024b9b

Violation Codes4
21 CFR 820.19821 CFR 820.3021 CFR 211.100(b)21 CFR 211.192

Full citation text and observation details available on the Dashboard.

Other documents for Almac Pharma Services LLC
  • 483 - 2025-08-22August 22, 2025
  • 483 - 2022-02-03February 3, 2022
  • 483 - 2017-12-07December 7, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Almac Pharma Services LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.